Search for: "Janssen Pharmaceuticals Inc."
Results 81 - 100
of 247
Sorted by Relevance
|
Sort by Date
5 Dec 2022, 6:55 am
In Teva Branded Pharmaceutical Products R&D, Inc. v. [read post]
5 Dec 2022, 6:55 am
In Teva Branded Pharmaceutical Products R&D, Inc. v. [read post]
5 Dec 2022, 6:55 am
In Teva Branded Pharmaceutical Products R&D, Inc. v. [read post]
Xarelto: Drug-Induced Liver Injury Reports Received By Health Canada And Found In Medical Literature
8 Sep 2015, 1:15 pm
Given these numerous case reports made to Health Canada and documented in medical articles, one wonders whether the responsible drug company, Janssen Pharmaceuticals, Inc., should increase the drug label warnings about hepatic / liver side effects such as acute liver failure, which can be fatal in some instances. [read post]
13 Aug 2009, 4:07 am
Janssen Pharmaceutical, Inc., ___ A.2d ___, 2009 WL 1857395 (Pa. [read post]
28 Feb 2014, 9:27 pm
(Hereinafter “Janssen”); (2) Johnson & Johnson; (3) Johnson & Johnson Pharmaceutical Research & Development, L.L.C; (4) Excerpta Medica Inc.; and (5) Elsevier Inc. [read post]
14 Jan 2014, 5:39 am
Mutual Pharmaceutical Co., Inc. [read post]
27 Sep 2009, 2:30 pm
As we noted in Genentech, Inc. v. [read post]
31 Jan 2013, 7:30 am
(Nasdaq: MYL) announced that it, along with Famy Care Ltd., has entered into a settlement agreement with Janssen Pharmaceuticals Inc. that will resolve patent litigation related to Ortho Tri-Cyclen Lo® Tablets, which are indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception. [read post]
26 Jun 2013, 6:30 am
(Nasdaq: MYL) announced that it, along with Famy Care Ltd., has entered into a settlement agreement with Janssen Pharmaceuticals Inc. that will resolve patent litigation related to Ortho Tri-Cyclen Lo® Tablets, which are indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception. [read post]
1 Mar 2013, 6:28 am
(Nasdaq: MYL) announced that it, along with Famy Care Ltd., has entered into a settlement agreement with Janssen Pharmaceuticals Inc. that will resolve patent litigation related to Ortho Tri-Cyclen Lo® Tablets, which are indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception. [read post]
24 Nov 2009, 1:11 am
Other defendants named in the MDL include Bristol-Myers Squibb Co., Solvay Pharmaceuticals Inc., Watson Pharmaceuticals Inc. and Ortho-McNeil Janssen Pharmaceuticals Inc. [read post]
24 Nov 2009, 1:11 am
Other defendants named in the MDL include Bristol-Myers Squibb Co., Solvay Pharmaceuticals Inc., Watson Pharmaceuticals Inc. and Ortho-McNeil Janssen Pharmaceuticals Inc. [read post]
29 Nov 2017, 5:00 am
Janssen Pharmaceuticals, Inc., 2017 Pa. [read post]
24 Jan 2012, 8:29 am
”Janssen issued this statement:"Janssen Pharmaceuticals, Inc. announced today it has reached a settlement with the State of Texas in ongoing litigation related to sales and marketing of the anti-psychotic prescription medication Risperdal (risperidone).Read more: http://www.philly.com/philly/blogs/phillypharma/Reports-JJ-settles-with-Texas-on-Risperdal-anti-psychotic-drug-case.html#ixzz1kOU05xZ4 [read post]
24 Oct 2014, 7:56 am
Janssen Pharmaceuticals, Inc., No. 3:12-oe-40003, 2014 U.S. [read post]
10 Jul 2017, 3:00 am
Portnoff v Janssen Pharmaceuticals Inc, 2017 WL 708745 (E.D. [read post]
23 Nov 2015, 8:00 am
Janssen Pharmaceuticals Inc., Johnson & Johnson Company and Johnson Pharmaceutical Research and Development, LLC, No. 130401990, Philadelphia County, Court of Common Pleas (Nov. 11, 2015). [read post]
6 May 2016, 8:00 am
Related blog posts: $124 Million Penalty to Stand Against the Drug Maker Janssen for the Drug Risperdal $90 Million Settlement Paid by Pharmaceutical Company For Its Unfair and Deceptive Promotion of Diabetes Drug Xarelto Lawsuits are Underway in Multi-district Litigation in the U.S. [read post]
21 Jun 2015, 6:17 pm
Por estas razones, se desestimaron las causas de acción y de igual manera las causas de acción bajo las leyes locales contra Johnson & Johnson Services, Inc., Janssen Cilag Mfg., LLC; Janssen Ortho, LLC. [read post]
